Injectable collagen for soft tissue augmentation.

Plastic and reconstructive surgery 1977 Vol.60(3) p. 398-405

Knapp TR, Kaplan EN, Daniels JR

Abstract

Collagen from allogenic and xenogeneic sources has been made soluble by controlled proteolytic digestion. The monomeric, telopeptide-poor collagen so prepared forms a cohesive mass when warmed to body temperature (upon injection), creating a structural basis for new soft connective tissue. We have treated 28 patients with human and/or bovine collagen injections for the correction of soft tissue contour defects, and we have followed them for 3 to 18 months. In most instances, there has been lasting and substantial correction of the defects treated. The complications have been few and transient.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 soft tissue scispacy 1
해부 soft connective tissue scispacy 1
기타 collagen scispacy 1
기타 telopeptide-poor collagen scispacy 1
기타 patients scispacy 1
기타 human scispacy 1
기타 bovine collagen scispacy 1

MeSH Terms

Acne Keloid; Animals; Cattle; Cellulitis; Collagen; Female; Folliculitis; Follow-Up Studies; Humans; Injections, Intradermal; Injections, Subcutaneous; Male; Pigmentation Disorders; Rats; Skin Diseases; Surgery, Plastic; Transplantation, Homologous; Urticaria